Non-Insulin Therapies For Diabetes Market Report 2026
Download Free Sample Buy Now
Non-Insulin Therapies For Diabetes Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Non-Insulin Therapies For Diabetes Market Report 2026

Global Outlook – By Type (Biguanides, Sulfonylureas, Thiazolidinediones (TZDs), DPP 4 Inhibitors, GLP 1 Analogs Or Agonists, SGLT2 Inhibitors), By Route Of Administration (Oral, Injectable), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals Or Clinics, Homecare Or Patients, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-Insulin Therapies For Diabetes Market Overview

• Non-Insulin Therapies For Diabetes market size has reached to $21.21 billion in 2025

• Expected to grow to $28.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: Role of Non-Insulin Therapies in Addressing the Global Diabetes Epidemic

• Market Trend: Advancements In Non-Insulin GLP-1 Therapies Enhance Treatment Outcomes In Diabetes And Weight Management

• North America was the largest region in 2025.

What Is Covered Under Non-Insulin Therapies For Diabetes Market?

Non-insulin therapies for diabetes refer to medications and treatments used to manage blood sugar levels in diabetic patients without the use of insulin injections. They are essential for regulating blood sugar levels in patients, who either do not need or prefer insulin injections.

The main classes of drugs in non-insulin therapies for diabetes market are biguanides, sulfonylureas, thiazolidinedione’s, alpha-glucosidase inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) analogs, and sodium-glucose co-transporter-2 (SGLT2) inhibitors. Biguanides are oral hypoglycemic agents that treat type 2 diabetes by reducing liver glucose production and enhancing insulin sensitivity. These medications are available for administration via oral and intramuscular routes and are distributed through various channels, including retail pharmacies, hospital pharmacies, and online pharmacies. They are used for monitoring, diagnosis, treatment, and others.

Non-Insulin Therapies For Diabetes Market Global Report 2026 Market Report bar graph

What Is The Non-Insulin Therapies For Diabetes Market Size and Share 2026?

The non-insulin therapies for diabetes market size has grown strongly in recent years. It will grow from $21.21 billion in 2025 to $22.59 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to high prevalence of type 2 diabetes, reliance on oral hypoglycemic agents, limited patient adherence to insulin therapy, growth in hospital and retail pharmacy distribution, emergence of multiple drug classes.

What Is The Non-Insulin Therapies For Diabetes Market Growth Forecast?

The non-insulin therapies for diabetes market size is expected to see strong growth in the next few years. It will grow to $28.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rise in adoption of non-insulin drug combinations, increasing use of glp-1 and sglt2 inhibitors, expansion of online pharmacy channels, growing personalized and precision medicine approaches, advancing integration of digital health and remote monitoring. Major trends in the forecast period include rising adoption of personalized diabetes management, increasing use of ai-driven glucose monitoring systems, growing integration of telemedicine-linked therapy solutions, expanding implementation of data-driven clinical decision support, advancing deployment of connected devices for remote patient care.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Non-Insulin Therapies For Diabetes Market Segmentation

1) By Type: Biguanides, Sulfonylureas, Thiazolidinediones (TZDs), DPP 4 Inhibitors, GLP 1 Analogs Or Agonists, SGLT2 Inhibitors

2) By Route Of Administration: Oral, Injectable

3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals Or Clinics, Homecare Or Patients, Other End-Users

Subsegments:

1) By Biguanides: Metformin, Combination Of Metformin With Other Drugs

2) By Sulfonylureas: Glimepiride, Glipizide, Glyburide

3) By Thiazolidinediones (TZDs): Pioglitazone, Rosiglitazone

4) By DPP 4 Inhibitors: Sitagliptin, Saxagliptin, Linagliptin

5) By GLP 1 Analogs Or Agonists: Exenatide, Liraglutide, Dulaglutide

6) By SGLT2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin

What Is The Driver Of The Non-Insulin Therapies For Diabetes Market?

The increase in the prevalence of diabetes is expected to propel the growth of non-insulin therapies for the diabetes market going forward. Diabetes is a chronic medical condition characterized by high blood glucose (sugar) levels. It occurs when the body cannot produce enough insulin or properly use the insulin it makes. The cases of diabetes is growing due to sedentary lifestyles, unhealthy diets, genetic predisposition, aging populations, obesity, ethnicity, lack of awareness, limited access to healthcare, and environmental factors. Non-insulin therapies for diabetes help treat the condition by improving insulin sensitivity, reducing glucose production in the liver, increasing glucose uptake in muscle cells, and enhancing overall glycemic control. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government agency, the GP-recorded prevalence of type 2 diabetes among adults aged 17 and over rose to 7.0%, up from 6.8% in March 2023. Therefore, the increase in the prevalence of diabetes is driving the growth of non-insulin therapies for the diabetes market.

Key Players In The Global Non-Insulin Therapies For Diabetes Market

Major companies operating in the non-insulin therapies for diabetes market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi, The Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Les Servier Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Uni-Bio Science Group Ltd., Intarcia Therapeutics, Janssen Pharmaceuticals, Boan Biotech, SatRx LLC

Global Non-Insulin Therapies For Diabetes Market Trends and Insights

Major companies operating in the non-insulin therapies for diabetes market are focusing on developing advanced solutions, such as non-insulin GLP-1 receptor agonist, to expand treatment options, improve glycemic control, and strengthen their competitive position in the diabetes and obesity care landscape. Non-insulin GLP-1 receptor agonist launch refers to the introduction of therapies that target GLP-1 receptors to support blood glucose regulation and weight reduction without the use of insulin. For instance, in March 2025, Eli Lilly and Company, a US-based pharmaceutical company specializing in diabetes and metabolic therapies, launched Mounjaro (tirzepatide) in India following approval from the Central Drugs Standard Control Organisation. Designed as a dual GIP and GLP-1 receptor agonist, Mounjaro addresses key challenges in type 2 diabetes and obesity management by offering once-weekly subcutaneous administration, enhancing glycemic control, reducing appetite, slowing gastric emptying, and supporting significant weight reduction, with dosing options starting at 2.5 mg and 5 mg to improve patient adherence and long-term outcomes.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Non-Insulin Therapies For Diabetes Market?

In August 2023, Eli Lilly and Company, a US-based pharmaceutical company, acquired Sigilon Therapeutics Inc. for $309.6 million. This acquisition enables Lilly to advance its research and development of encapsulated cell therapies, such as SIG-002, for treating type 1 diabetes. The aim is to offer improved solutions that relieve individuals with type 1 diabetes from continuous disease management. Sigilon Therapeutics Inc. is a US-based biopharmaceutical company developing encapsulated cell therapies for treating type 1 diabetes.

Regional Outlook

North America was the largest region in the non-insulin therapies for diabetes market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Insulin Therapies For Diabetes Market?

The non-insulin therapies for diabetes market consist of sales of glucose meters, continuous glucose monitors (CGMs), insulin pumps, smart insulin pens, oral medications such as metformin and sulfonylureas, and injectable medications such as glp-1 receptor agonists. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Insulin Therapies For Diabetes Market Report 2026?

The non-insulin therapies for diabetes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-insulin therapies for diabetes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Non-Insulin Therapies For Diabetes Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $22.59 billion
Revenue Forecast In 2035 $28.39 billion
Growth Rate CAGR of 6.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Route Of Administration, Application, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi, The Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Les Servier Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Uni-Bio Science Group Ltd., Intarcia Therapeutics, Janssen Pharmaceuticals, Boan Biotech, SatRx LLC
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Non-Insulin Therapies For Diabetes Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Non-Insulin Therapies For Diabetes Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Non-Insulin Therapies For Diabetes Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Non-Insulin Therapies For Diabetes Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Personalized Diabetes Management

4.2.2 Increasing Use Of Ai-Driven Glucose Monitoring Systems

4.2.3 Growing Integration Of Telemedicine-Linked Therapy Solutions

4.2.4 Expanding Implementation Of Data-Driven Clinical Decision Support

4.2.5 Advancing Deployment Of Connected Devices For Remote Patient Care

5. Non-Insulin Therapies For Diabetes Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Retail Pharmacies

5.3 Hospital Pharmacies

5.4 Online Pharmacies

5.5 Diabetic Clinics

6. Non-Insulin Therapies For Diabetes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Insulin Therapies For Diabetes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Non-Insulin Therapies For Diabetes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Non-Insulin Therapies For Diabetes Market Size, Comparisons And Growth Rate Analysis

7.3. Global Non-Insulin Therapies For Diabetes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Non-Insulin Therapies For Diabetes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Insulin Therapies For Diabetes Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Insulin Therapies For Diabetes Market Segmentation

9.1. Global Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biguanides, Sulfonylureas, Thiazolidinediones (TZDs), DPP 4 Inhibitors, GLP 1 Analogs Or Agonists, SGLT2 Inhibitors

9.2. Global Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable

9.3. Global Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes

9.4. Global Non-Insulin Therapies For Diabetes Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Non-Insulin Therapies For Diabetes Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals Or Clinics, Homecare Or Patients, Other End-Users

9.6. Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metformin, Combination Of Metformin With Other Drugs

9.7. Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Sulfonylureas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Glimepiride, Glipizide, Glyburide

9.8. Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Thiazolidinediones (TZDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pioglitazone, Rosiglitazone

9.9. Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of DPP 4 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sitagliptin, Saxagliptin, Linagliptin

9.10. Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of GLP 1 Analogs Or Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Exenatide, Liraglutide, Dulaglutide

9.11. Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of SGLT2 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Canagliflozin, Dapagliflozin, Empagliflozin

10. Non-Insulin Therapies For Diabetes Market Regional And Country Analysis

10.1. Global Non-Insulin Therapies For Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Non-Insulin Therapies For Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Insulin Therapies For Diabetes Market

11.1. Asia-Pacific Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Insulin Therapies For Diabetes Market

12.1. China Non-Insulin Therapies For Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Insulin Therapies For Diabetes Market

13.1. India Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Insulin Therapies For Diabetes Market

14.1. Japan Non-Insulin Therapies For Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Insulin Therapies For Diabetes Market

15.1. Australia Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Insulin Therapies For Diabetes Market

16.1. Indonesia Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Insulin Therapies For Diabetes Market

17.1. South Korea Non-Insulin Therapies For Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Insulin Therapies For Diabetes Market

18.1. Taiwan Non-Insulin Therapies For Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Insulin Therapies For Diabetes Market

19.1. South East Asia Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Insulin Therapies For Diabetes Market

20.1. Western Europe Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Insulin Therapies For Diabetes Market

21.1. UK Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Insulin Therapies For Diabetes Market

22.1. Germany Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Insulin Therapies For Diabetes Market

23.1. France Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Insulin Therapies For Diabetes Market

24.1. Italy Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Insulin Therapies For Diabetes Market

25.1. Spain Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Insulin Therapies For Diabetes Market

26.1. Eastern Europe Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Insulin Therapies For Diabetes Market

27.1. Russia Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Insulin Therapies For Diabetes Market

28.1. North America Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Insulin Therapies For Diabetes Market

29.1. USA Non-Insulin Therapies For Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Insulin Therapies For Diabetes Market

30.1. Canada Non-Insulin Therapies For Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Insulin Therapies For Diabetes Market

31.1. South America Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Insulin Therapies For Diabetes Market

32.1. Brazil Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Insulin Therapies For Diabetes Market

33.1. Middle East Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Insulin Therapies For Diabetes Market

34.1. Africa Non-Insulin Therapies For Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Insulin Therapies For Diabetes Market Regulatory and Investment Landscape

36. Non-Insulin Therapies For Diabetes Market Competitive Landscape And Company Profiles

36.1. Non-Insulin Therapies For Diabetes Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Non-Insulin Therapies For Diabetes Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Non-Insulin Therapies For Diabetes Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi Overview, Products and Services, Strategy and Financial Analysis

36.3.5. The Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Non-Insulin Therapies For Diabetes Market Other Major And Innovative Companies

AstraZeneca plc, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Les Servier Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Uni-Bio Science Group Ltd., Intarcia Therapeutics, Janssen Pharmaceuticals, Boan Biotech, SatRx LLC

38. Global Non-Insulin Therapies For Diabetes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Insulin Therapies For Diabetes Market

40. Non-Insulin Therapies For Diabetes Market High Potential Countries, Segments and Strategies

40.1 Non-Insulin Therapies For Diabetes Market In 2030 - Countries Offering Most New Opportunities

40.2 Non-Insulin Therapies For Diabetes Market In 2030 - Segments Offering Most New Opportunities

40.3 Non-Insulin Therapies For Diabetes Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Non-Insulin Therapies For Diabetes Market, Overview Of Key Products - Product Examples
  • Table 2: Global Non-Insulin Therapies For Diabetes Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Non-Insulin Therapies For Diabetes Market, Supply Chain Analysis
  • Table 4: Global Non-Insulin Therapies For Diabetes Market, Major Raw Material Providers
  • Table 5: Global Non-Insulin Therapies For Diabetes Market, Major Resource Providers
  • Table 6: Global Non-Insulin Therapies For Diabetes Market, Major Manufacturers (Suppliers)
  • Table 7: Global Non-Insulin Therapies For Diabetes Market, Major Distributors And Channel Partners
  • Table 8: Global Non-Insulin Therapies For Diabetes Market, Key Technologies & Future Trends
  • Table 9: Global Non-Insulin Therapies For Diabetes Market, Major Trends
  • Table 10: Global Non-Insulin Therapies For Diabetes Market, Major End Users
  • Table 11: Global Non-Insulin Therapies For Diabetes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Non-Insulin Therapies For Diabetes Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Non-Insulin Therapies For Diabetes Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Non-Insulin Therapies For Diabetes Market - TAM, US$ Billion, 2025
  • Table 15: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Non-Insulin Therapies For Diabetes Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Sulfonylureas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Thiazolidinediones (TZDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of DPP 4 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of GLP 1 Analogs Or Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of SGLT2 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Non-Insulin Therapies For Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Global Non-Insulin Therapies For Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Asia-Pacific, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: China, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: India, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Japan, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Australia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Indonesia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South Korea, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Taiwan, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: South East Asia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Western Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: UK, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Germany, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: France, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Italy, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Spain, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Eastern Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Russia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: North America, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: USA, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Canada, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: South America, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Brazil, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Middle East, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Africa, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Global Non-Insulin Therapies For Diabetes Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 101: Global Non-Insulin Therapies For Diabetes Market - Company Scoring Matrix
  • Table 102: Pfizer Inc. Financial Performance
  • Table 103: F. Hoffmann-La Roche AG Financial Performance
  • Table 104: Merck & Co. Inc. Financial Performance
  • Table 105: Sanofi Financial Performance
  • Table 106: The Bristol-Myers Squibb Company Financial Performance
  • Table 107: Global Non-Insulin Therapies For Diabetes Market, Competitive Benchmarking (In USD Billions)
  • Table 108: Global Non-Insulin Therapies For Diabetes Market, Competitive Dashboard
  • Table 109: Global Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 110: Global, Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 111: Global, Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 112: Global, Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Non-Insulin Therapies For Diabetes Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Non-Insulin Therapies For Diabetes Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Non-Insulin Therapies For Diabetes Market, Supply Chain Analysis
  • Figure 4: Global Non-Insulin Therapies For Diabetes Market, Major Raw Material Providers
  • Figure 5: Global Non-Insulin Therapies For Diabetes Market, Major Resource Providers
  • Figure 6: Global Non-Insulin Therapies For Diabetes Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Non-Insulin Therapies For Diabetes Market, Major Distributors And Channel Partners
  • Figure 8: Global Non-Insulin Therapies For Diabetes Market, Key Technologies & Future Trends
  • Figure 9: Global Non-Insulin Therapies For Diabetes Market, Major Trends
  • Figure 10: Global Non-Insulin Therapies For Diabetes Market, Major End Users
  • Figure 11: Global Non-Insulin Therapies For Diabetes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Non-Insulin Therapies For Diabetes Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Non-Insulin Therapies For Diabetes Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Non-Insulin Therapies For Diabetes Market - TAM, US$ Billion, 2025
  • Figure 15: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Non-Insulin Therapies For Diabetes Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Non-Insulin Therapies For Diabetes Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Sulfonylureas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of Thiazolidinediones (TZDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of DPP 4 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of GLP 1 Analogs Or Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Non-Insulin Therapies For Diabetes Market, Sub-Segmentation Of SGLT2 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Non-Insulin Therapies For Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Global Non-Insulin Therapies For Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Asia-Pacific, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: China, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: India, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Japan, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Australia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Indonesia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South Korea, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Taiwan, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: South East Asia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Western Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: UK, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Germany, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: France, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Italy, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Spain, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Eastern Europe, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Russia, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: North America, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: USA, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Canada, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: South America, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Brazil, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Middle East, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Non-Insulin Therapies For Diabetes Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Non-Insulin Therapies For Diabetes Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Africa, Non-Insulin Therapies For Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Global Non-Insulin Therapies For Diabetes Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 101: Global Non-Insulin Therapies For Diabetes Market - Company Scoring Matrix
  • Figure 102: Pfizer Inc. Financial Performance
  • Figure 103: F. Hoffmann-La Roche AG Financial Performance
  • Figure 104: Merck & Co. Inc. Financial Performance
  • Figure 105: Sanofi Financial Performance
  • Figure 106: The Bristol-Myers Squibb Company Financial Performance
  • Figure 107: Global Non-Insulin Therapies For Diabetes Market, Competitive Benchmarking (In USD Billions)
  • Figure 108: Global Non-Insulin Therapies For Diabetes Market, Competitive Dashboard
  • Figure 109: Global Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 110: Global, Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 111: Global, Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 112: Global, Non-Insulin Therapies For Diabetes Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Non-Insulin Therapies For Diabetes Market Report 2026 - Global Outlook – By Type (Biguanides, Sulfonylureas, Thiazolidinediones (TZDs), DPP 4 Inhibitors, GLP 1 Analogs Or Agonists, SGLT2 Inhibitors), By Route Of Administ...

Non-injectable Insulin Market Report 2026 - Global Outlook – By Insulin Type (Oral Insulin, Inhaled Insulin, Nasal Insulin, Buccal Or Sublingual Insulin, Transdermal Insulin), By Product (Pills, Sprays, Other Products), ...

OEM Insulation Market Report 2026 - Global Outlook – By Insulation Type (Blankets, Rolls And Batts, Other Insulation Types ), By Material Type (Mineral Wool, Polyurethane Foam (PUF), Flexible Elastomeric Foam (FEF), Othe...

Antidiabetics Market Report 2026 - Global Outlook – By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes), By Diabetes Type (Type 1, Type 2), By Patient Population (Ant...

Antidiabetics Market Report 2026 - Global Outlook – By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes), By Diabetes Type (Type 1, Type 2), By Patient Population (Ant...

Insuman Market Report 2026 - Global Outlook – By Patient Demographics (Pediatric Patients, Adult Patients, Elderly Patients), By Distribution Channel (Hospitals, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies...

Clinical Nutrition For Diabetes Care Market Report 2026 - Global Outlook – By Product (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Stage (Adult, Pediatric), By Sales Channel (Online, Retail, Insti...

Instant Tea Premix Market Report 2026 - Global Outlook – By Product type (Cardamom Tea Premix, Ginger Tea Premix, Masala Tea Premix, Lemon Tea Premix, Plain Tea Premix, Lemon Grass Tea Premix), By Nature (Organic Tea Pre...

Frequently Asked Questions

The Non-Insulin Therapies For Diabetes market was valued at $21.21 billion in 2025, increased to $22.59 billion in 2026, and is projected to reach $28.39 billion by 2030. request a sample here

The global Non-Insulin Therapies For Diabetes market is expected to grow at a CAGR of 5.9% from 2026 to 2035 to reach $28.39 billion by 2035. request a sample here

Some Key Players in the Non-Insulin Therapies For Diabetes market Include, Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi, The Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Les Servier Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Uni-Bio Science Group Ltd., Intarcia Therapeutics, Janssen Pharmaceuticals, Boan Biotech, SatRx LLC . request a sample here

Major trend in this market includes: Advancements In Non-Insulin GLP-1 Therapies Enhance Treatment Outcomes In Diabetes And Weight Management. For further insights on this market. request a sample here

North America was the largest region in the non-insulin therapies for diabetes market in 2025. The regions covered in the non-insulin therapies for diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Non-Insulin Therapies For Diabetes Market Report 2026 market are Major companies operating in the non-insulin therapies for diabetes market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi, The Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Les Servier Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Uni-Bio Science Group Ltd., Intarcia Therapeutics, Janssen Pharmaceuticals, Boan Biotech, SatRx LLC request a sample here.

North America was the largest region in the non-insulin therapies for diabetes market in 2025. The regions covered in the non-insulin therapies for diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us